On April 11, 2022, Caroline Levy notified ChromaDex Corporation (the Company) of her intention to resign from the Board and as a member of the Audit Committee and Nominating and Corporate Governance Committee of the Board. The effective date of Ms. Levy's resignation is April 11, 2022. Ms. Levy's decision to resign is not due to any disagreement with the Company on any matter relating to its operations, policies or practices.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.18 USD | +3.25% | +9.46% | +118.92% |
06-07 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
06-07 | ChromaDex Says US FDA Grants NRC Orphan Drug, Rare Pediatric Disease Designations -- Shares Climb Pre-Bell | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+118.92% | 233M | |
+46.76% | 56.87B | |
+38.28% | 39.72B | |
-6.23% | 39.27B | |
-6.90% | 28.73B | |
+13.81% | 26.21B | |
-16.70% | 19.79B | |
+32.25% | 12.28B | |
+28.26% | 12.23B | |
+0.13% | 12.12B |
- Stock Market
- Equities
- CDXC Stock
- News ChromaDex Corporation
- Caroline Levy Notifies Her Intention to Resign from the Board and as Member of the Audit Committee and Nominating and Corporate Governance Committee of the Board of Chromadex Corporation